ATPC agapeatpgroup.com Earnings growth forecast for next year

Corporate emblem and logo of Agape ATP Corp. (ATPC)

Cash flows for Agape ATP Corporation are moderately stable and depend on the activity of Asian distributors. Agape ATP Corporation is developing a preventive medicine complex, combining dietary supplements and digital wellness, while the holding's R&D activity is currently minimal. The current trajectory of next year's EPS forecasts reflects the dynamics of fundamental valuations, with the metric level standing at 0.00.

Agape ATP Corp. (ATPC): Expected net earnings per share growth next year from 02/21/2024 to 11/16/2026

ATPC (Agape ATP Corp.): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Initial company analysis:ATPC, Agape ATP Corp
Finished products of Agape ATP Corp

Institutional capital assesses the investment attractiveness of Agape ATP Corporation (ATPC) through the lens of future profitability. The company's forward EPS dynamics model aggregates current analyst forecasts for annual net profit growth, filtering out market noise to identify the true earnings trend. Given the implementation of ESG standards and resource optimization in dietary supplement production, the growth of this indicator confirms the resilience of the business model and the long-term reliability of the asset.

Analysis of competing companies

ASND (Ascendis) - Earnings growth forecast for next year|Earnings growth forecast for next year Madrigal Pharmaceuticals|Earnings growth forecast for next year CORT|Net earnings per share growth forecast for next year RYTM (Rhythm Pharma)|Net earnings per share growth forecast for next year akerotx.com AKRO|Metsera Therapeutics (MTSR) - Expected net earnings per share growth next year|MLTX - Net earnings per share growth forecast for next year|CRNX: Net earnings per share growth forecast for next year|NAMS: Earnings growth forecast for next year|SLNO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Amicus Corp|89bio Pharma (ETNB) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agios.com (AGIO)|Expected earnings per share growth for next year structuretx.com GPCR|Net earnings per share growth forecast for next year MiMedx Group Inc MDXG|Expected earnings per share trend next year RZLT|lexpharma.com - Earnings growth forecast for next year|MBX (MBX Biosciences Inc) - Projected earnings per share growth rate for next year|ALT: Earnings growth forecast for next year|Aardvark Therapeutics Inc - Expected earnings per share trend next year|SGMT (Sagimet Biosciences, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year BioAge|Earnings growth forecast for next year BMEA|Expected earnings per share growth for next year Quince Therapeutics, Inc. QNCX|Fractyl Health Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year VTVT|Pluristem Therapeutics - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year synlogictx.com SYBX|LPCN: Earnings growth forecast for next year|Matinas BioPharma Holdings, Inc. - Expected earnings per share trend next year|SPRB (Spruce Biosciences Inc.) - Earnings growth forecast for next year|galecto.com (GLTO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year organovo.com ONVO|Radius Health (RDUS) - Expected net earnings per share growth next year